Graphite Bio, Inc. (GRPH) Financials

GRPH Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 188.5 million 4.9 million
Sept. 30, 2023 266.2 million 62.2 million
June 30, 2023 287.0 million 62.9 million
March 31, 2023 310.0 million 33.8 million

GRPH Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -45.9 million 2.3 million
Sept. 30, 2023 -14.2 million 2.2 million
June 30, 2023 -19.3 million 2.8 million
March 31, 2023 -21.5 million 3.3 million

GRPH Net Income

No data available :(

GRPH Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 185.9 million - 362000
Sept. 30, 2023 234.0 million - 53.1 million
June 30, 2023 246.7 million - 53.5 million
March 31, 2023 264.1 million - 4.5 million

GRPH Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 58.0 million
Sept. 30, 2023 57.3 million
June 30, 2023 56.7 million
March 31, 2023 55.9 million

GRPH Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 50000 1000 14.6 million 142000
Sept. 30, 2023 4.8 million 2.4 million 11.3 million -
June 30, 2023 5.6 million 13.5 million 7.5 million -
March 31, 2023 383000 16.2 million 7.6 million -

GRPH Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 10.2 million 142000
Sept. 30, 2023 - 800000
June 30, 2023 - 2.1 million
March 31, 2023 - 2.2 million

GRPH

Price: $3.18

52 week price:
2.01
28.56

Forward Dividend Yield: 32.39%

Dividend Per Share: 1.03 USD

Earnings Per Share: -2.23 USD

P/E Ratio: -1.37

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 124104

Market Capitalization: 189.8 million

Years Paying Dividends: 1

Links: